Skip to main content
SpringerLink
Log in

Effects of Several Glucocorticosteroids and PDE4 Inhibitors on Increases in Total Lung Eosinophil Peroxidase (EPO) Levels Following Either Systemic or Intratracheal Administration in Sephadexor Ovalbumin-induced Inflammatory Models

  • Published:
Inflammation Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

Representative glucocorticosteroids (GCS) and phosphodiesterase IV (PDE4) inhibitors were compared in several models of pulmonary inflammation ranging in severity. Lung tissue eosinophil peroxidase (EPO) levels rather than bronchoalveolar lavage fluid (BALF) EPO or eosinophil percentages were used to indicate eosinophil recruitment after intratracheal instillation of sephadex beads in rats or nebulized ovalbumin in sensitized guinea pigs. A single oral or intratracheal administration of a GCS was effective against mild and robust sephadex-induced eosinophilia whereas the PDE4 inhibitors evaluated appeared more effective in the milder sephadex models. The GCS were also more effective against sephadex-induced than ovalbumin-induced eosinophilia. The effectiveness of the GCS and PDE4 inhibitors improved when the severity of the ovalbumin-induced eosinophilia was decreased. Multiple day dosing also improved activity. These studies indicated that activity was influenced greatly by administration protocols, the severity of the inflammatory response and possibly the method used for estimating eosinophil recruitment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. BOUSQUET, J., P. CHANEZ, J. Y. LACOSTE, G. BARNEON, N. GHAVANIAN, I. ENANDER, P. VENGE, S. AHLSTEDT, J. SIMONY LAFONTAINE, P. GODARD, and F. B. MICHEL. 1990. Eosinophilic inflammation in asthma. N. Engl. J. Med., 323:1033-1039.

    Google Scholar 

  2. SEARS, M. R. 1993. The definition and diagnosis of asthma. Allergy, 48:12-16.

    Google Scholar 

  3. SZEFLER, S. J. 1991. Glucocorticosteroid therapy for asthma: clinical pharmacology. J. Allergy Clin. Immunol., 88:147-165.

    Google Scholar 

  4. LAITINEN, L. A., A. LAITINEN, and T. HAAHTELA. 1992. A comparative study of the effects of an inhaled corticosteroid, budesonide, and β2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a random, double-blind, parallel-group controlled trial. J. Allergy Clin. Immunol., 90:32-42.

    Google Scholar 

  5. SCHLEIMER, R. P. 1993. An overview of glucocorticoid anti-inflammatory actions. Eur. J. Clin Pharmacol., 45:S3-S7.

    Google Scholar 

  6. TINKELMAN, D. G., C. REED, H. S. NELSON, and K. P. OFFORD. 1993. Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. Pediatrics, 92:64-77.

    Google Scholar 

  7. AGERTFT, T., and S. PEDERSEN. 1994. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Repir. Med., 88:373-381.

    Google Scholar 

  8. SANTING, R. E., C. G. OLYMULDER, K. VAN DER MOLEN, H. MEURS, and J. ZAAGSMA. 1995. Phosphodiesterase inhibitors reduce bronchial hyperreactivity and airway inflammation in unrestrained guinea pigs. Eur. J. Pharmacol., 275:75-82.

    Google Scholar 

  9. TEIXEIRA, M. M., R. W. GRISTWOOD, N. COOPER, and P. G. HELLEWELL. 1997. Phosphodiesterase(PDE)4 inhibitors: anti-inflammatory drugs of the future? Trends Pharmacol. Sci., 18:164-170.

    Google Scholar 

  10. KALLSTROM, L., R. BRATTSAND, U. LOVEGREN, E. SVENSJO, and K. ROEMPKE. 1985. A rat model for testing anti-inflammatory action in lung and the effect of glucocorticosteroids(GCS) in this model. Agents and Actions, 17:355-357.

    Google Scholar 

  11. SPICER, B. A., R. C. BAKER, P. A. HATT, S. M. LAYCOCK, and H. SMITH. 1990. The effects of drugs on sephadex-induced eosinophilia and lung hyper-responsiveness in the rat. Br. J. Pharmacol., 101:821-828.

    Google Scholar 

  12. LINSSEN, M. J., O. H. WILHELMS, and H. TIMMERMAN. 1991. Animal models for testing antiinflammatory drugs for treatment of bronchial hyperreactivity in asthma. Pharm. Weekbl. [Sci.], 13:225-237.

    Google Scholar 

  13. RAEBURN, D., S. L. UNDERWOOD, S. A. LEWIS, V. R. WOODMAN, C. H. BATTRAM, A. TOMKINSON, S. SHARMA, R. JORDAN, J. E. SOUNESS, S. E. WEBBER, and J-A. KARLSSON. 1994. Anti-inflammatory and bronchodilator properties of RP73401, a novel and selective phosphodiesterase type IV inhibitor. Br. J. Pharmacol., 113:1423-1431.

    Google Scholar 

  14. UNDERWOOD, D. C., C. J. KOTZER, S. BOCHNOWICZ, R. R. OSBORN, M. A. LUTTMANN, D. W. P. HAY, and T. J. TROPHY. 1994. Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs. J. Pharmacol. Exp. Ther., 270:250-259.

    Google Scholar 

  15. BANNER, K. H., F. MARCHINI, A. BUSCHI, E. MORIGGI, C. SEMERARO, and C. P. PAGE. 1995. The effect of selective phosphodiesterase inhibitors in comparison with other anti-asthma drugs on allergen-induced eosinophilia in guinea pig airways. Pul. Pharmacol., 8:37-42.

    Google Scholar 

  16. BANNER, K., and C. L. PAGE. 1995. Acute and Chronic administration of phosphodiesterase inhibitors on allergen-induced pulmonary cell influx in sensitized guinea-pigs. Br. J. Pharmacol., 114:93-98.

    Google Scholar 

  17. HUGHES, B., D. HOWAT, H. LISLE, M. HOLBROOK, T. JAMES, N. GOZZARD, K. BLEASE, P. HUGHES, R. KINGABY, G. WARRELLOW, R. ALEXANDER, J. HEAD, E. BOYD, M. EATON, M. WALES, B. SMITH, R. OWENS, C. CATTERALL, S. LIMB, A. RUSSELL, R. ALLEN, M. MERRIMAN, D. BLOXHAM, and G. HIGGS. 1996. The inhibition of antigen-induced eosinophilia and bronchoconstriction by CDP-840, a novel stereo-selective inhibitor of phosphodiesterase type 4. Br. J. Pharmacol., 118:1183-1191.

    Google Scholar 

  18. HAMMERBECK, D. M., A. M. HUPPERTS, S. M. MCGURRAN, and G. W. GULLIKSON. 1997. Effects of several glucocorticosteroids on increases in total lung eosinophil peroxidase(EPO) levels and thymus involution in a sephadex-induced pulmonary inflammation model. Am. J. Respir. Crit. Care Med., 155:A623.

    Google Scholar 

  19. HAMMERBECK, D. M., S. M. MCGURRAN, A. M. HUPPERTS, J. OCHADA, G. COLICE, and G. W. GULLIKSON. 1997. Effects of several glucocorticosteroids on increases in total lung eosinophil peroxidase(EPO) levels following either systemic or intratracheal administration in sephadex-or ovalbumin-induced inflammatory models. Am. J. Respir. Crit. Care Med., 155:A623.

    Google Scholar 

  20. LAWRENCE, T. E., L. MILLECCHIA, and J. S. FEDAN. 1997. Fluticasone propionate and pentamidine isethionate reduce airway hyperreactivity, pulmonary eosinophilia and pulmonary dendritic cell response in a guinea pig model of asthma. J. Pharmacol. Exp. Ther., 284:222-227.

    Google Scholar 

  21. RYRFELDT, A., P. ANDERSSON, S. EDSBACKER, M. TONNESSON, D. DAVIES, and R. PAUWELS. 1982. Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid. Eur. J. Respir. Dis., 63(suppl. 122):86-95.

    Google Scholar 

  22. HOLLIDAY, S. M., D. FAULDS, and E. M. SORKIN. 1994. Inhaled fluticasone propionate: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma. Drugs., 47:318-331.

    Google Scholar 

  23. DUNNILL, M. S. 1971. The pathology of asthma. In: Porter, R. and J. Birch, eds. The identification of asthma. Edinburgh: Church-Livingston: 35-46.

    Google Scholar 

  24. WARDLAW, A. J., S. DUNNETTE, G. J. GLEICH, J. V. COLLINS, and A. B. KAY. 1988. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Am. Rev. Respir. Dis., 137:62-69.

    Google Scholar 

  25. GLEICH, G. J. 1990. The eosinophil and bronchial asthma: current understanding. N. Engl. J. Med., 321:1517-1527.

    Google Scholar 

  26. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention NHLBI/WHO Workshop Report. 1995. National Institutes of Health, National Heart, Lung, and Blood Institute.

  27. GEORGITIS, J. W. 1999. The 1997 Asthma Management Guidelines and therapeutic issues relating to the treatment of asthma. Chest, 115:210-217.

    Google Scholar 

  28. FILLEY, W. V., K. E. HOLLEY, G. M. KEPHART, and G. J. GLEICH. 1982. Identification by immunofluorescence of eosinophil granule major basic protein in lung tissues of patients with bronchial asthma. Lancet., 2:11-16.

    Google Scholar 

  29. WOOLCOCK, A. J., K. YAN, and C. M. SALOME. 1988. Effect of therapy on bronchial hyperresponsiveness in the long-term management of asthma. Clin. Allergy, 18:165-176.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. 3M Pharmaceuticals, 3M Company, St. Paul, Minnesota, 55144

    David M. Hammerbeck, Sean M. Mcgurran, Pam L. Radziszewski, Elaine A. Egging, David D. Johnson, Ann M. Hupperts & Gary W. Gullikson

Authors
  1. David M. Hammerbeck
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sean M. Mcgurran
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pam L. Radziszewski
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Elaine A. Egging
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. David D. Johnson
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ann M. Hupperts
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Gary W. Gullikson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hammerbeck, D.M., Mcgurran, S.M., Radziszewski, P.L. et al. Effects of Several Glucocorticosteroids and PDE4 Inhibitors on Increases in Total Lung Eosinophil Peroxidase (EPO) Levels Following Either Systemic or Intratracheal Administration in Sephadexor Ovalbumin-induced Inflammatory Models. Inflammation 24, 317–329 (2000). https://doi.org/10.1023/A:1007092830169

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007092830169

Keywords

Search

Navigation